Annexes - 2024 annual report of the European Medicines Agency

Annexes to the annual report of the European Medicines Agency 2024 Annex 1 – Members of the Management Board ............................................................................ 2 Annex 2 - Members of the Committee for Medicinal Products for Human Use ................................... 4 Annex 3 – Members of the Pharmacovigilance Risk Assessment Committee ..................................... 6 Annex 4 – Members of the Committee for Veterinary Medicinal Products ......................................... 8 Annex 5 – Members of the Committee on Orphan Medicinal Products ............................................ 10 Annex 6 – Members of the Committee on Herbal Medicinal Products ............................................. 12 Annex 7 – Committee for Advanced Therapies .......................................................................... 14 Annex 8 – Members of the Paediatric Committee ....................................................................... 16 Annex 9 – Working parties and working groups ......................................................................... 18 Annex 10 – CHMP opinions on initial evaluations and extensions of therapeutic indication in 2024 .... 22 Annex 11 – Guidelines and concept papers adopted by CHMP ...................................................... 23 Annex 12 – CVMP opinions in 2024 on medicinal products for veterinary use ................................. 30 Annex 13 – Guidelines and concept papers...